Related Experiment Video
Updated: Dec 23, 2025

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
Dirk Geerts1, Christina Chopra2, Linda Connelly2
1Department of Medical Biology, Academic Medical Center Amsterdam, Amsterdam, Netherlands.
Osteoprotegerin (OPG) plays a dual role in breast cancer, influencing bone remodeling and tumor biology. Conflicting data links OPG expression to both improved and worsened patient survival, necessitating further research.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteoprotegerin (OPG) is a TNF receptor superfamily member crucial for bone remodeling by inhibiting osteoclastogenesis via RANKL.
- OPG is also expressed in breast tumors, where it may influence tumor behavior independently of its bone-related functions.
- The role of OPG in breast cancer is complex, involving interactions with RANKL and TRAIL, and its prognostic significance remains debated.
Purpose of the Study:
- To review and summarize existing research on the role of Osteoprotegerin (OPG) in breast cancer.
- To analyze the conflicting clinical data regarding OPG expression and its correlation with breast cancer risk and patient prognosis.
- To stimulate further research to reconcile basic science findings with clinical observations of OPG in breast cancer.
Main Methods:
- Literature review of functional studies on OPG in breast cancer.
- Analysis of in vitro and in vivo research on OPG's role in tumor biology.
- Synthesis of data correlating OPG expression with breast cancer risk and patient survival outcomes.
Main Results:
- OPG's function extends beyond bone remodeling to modulate breast tumor behavior.
- OPG can interact with TRAIL to inhibit apoptosis in primary tumors.
- Clinical data on OPG's prognostic value in breast cancer is conflicting, with associations to both favorable and unfavorable survival.
Conclusions:
- OPG has a multifaceted role in breast cancer, impacting both the tumor microenvironment and primary tumor biology.
- The prognostic implications of OPG in breast cancer patients require further investigation to resolve conflicting findings.
- Bridging basic research and clinical data is essential for a comprehensive understanding of OPG's role in breast cancer.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle

